Effectiveness and safety of capecitabine, irinotecan and panitumumab in advanced colorectal cancer

INTRODUCTION: Capecitabine, irinotecan, and panitumumab (CAPIRI-P) is a controversial regimen for metastatic colorectal cancer, with concerns regarding the efficacy and toxicity. However, its toxicity profile has been improved with dose reduction, and concerns regarding efficacy have been extrapolat...

Descripción completa

Detalles Bibliográficos
Autores principales: Yip, Pui Lam, Fung, Wai Him Brian, Lee, Francis Ann Shing, Lee, Chak Fei, Wong, Natalie Sean Man, Lee, Shing Fung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116611/
https://www.ncbi.nlm.nih.gov/pubmed/37091154
http://dx.doi.org/10.3389/fonc.2023.1138357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116611/
https://www.ncbi.nlm.nih.gov/pubmed/37091154
http://dx.doi.org/10.3389/fonc.2023.1138357

Ejemplares similares